Pharma News

Keep updating your pharma knowledge
27 Nov 2014

What is 505(b)(2) applications?

/
Posted By
/
Comments0
/
505(b)(2) NDA allows drug companies to obtain Food and Drug Administration (FDA) approval of essentially “new” drugs without having to conduct the full complement of safety and efficacy trials, which is often the most time-consuming and expensive part of the drug development process. 
 

Leave a Reply


The reCAPTCHA verification period has expired. Please reload the page.

Upskill Your Pharma Knowledge

Explore Next Gen Learning

Case Studies & Caselets | Simulation Based Learning | E-Lectures | Online Self Competency Assessments

Thank You for Subscription!